Blood and intestine eqtls from an anti-Tnf-resistant crohn's disease cohort inform ibd genetic association loci

Clinical and Translational Gastroenterology

Volumn 7, Issue 6, 2016, Pages

  Di Narzo, Antonio F ^a   Peters, Lauren A ^a   Argmann, Carmen ^a   Stojmirovic, Aleksandar ^b   Perrigoue, Jacqueline ^b   Li, Katherine ^b   Telesco, Shannon ^b   Kidd, Brian ^a   Walker, Jennifer ^a   Dudley, Joel ^a   Cho, Judy ^a   Schadt, Eric E ^a   Kasarskis, Andrew ^a   Curran, Mark ^b   Dobrin, Radu ^b   Hao, Ke ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BUDESONIDE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; PREDNISOLONE; TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; BLOOD SAMPLING; CLINICAL OUTCOME; CROHN DISEASE; EXPRESSION QUANTITATIVE TRAIT LOCUS; FALSE DISCOVERY RATE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE TISSUE; PATHWAY ENRICHMENT ANALYSIS; REGULATORY MECHANISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 85020902910     PISSN: 2155384X     EISSN: None     Source Type: Journal    
DOI: 10.1038/ctg.2016.34     Document Type: Article

References (80)

1. Guo C, DIppolito AM, Reddy TE. From prescription to transcription: genome sequence as drug target. Cell 2015; 162: 16 17.
2. Soccio RE, Chen ER, Rajapurkar SR et al. Genetic variation determines PPARgamma function and anti-diabetic drug response In Vivo. Cell 2015; 162: 33 44.
3. Mathews RJ, Robinson JI, Battellino M et al. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann Rheum Dis 2014; 73: 1202 1210.
4. Krausgruber T, Saliba D, Ryzhakov G et al. IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood 2010; 115: 4421 4430.
5. Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol 2014; 14: 329 342.
6. Jostins L, Ripke S, Weersma RK et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119 124.
7. Schadt EE, Molony C, Chudin E et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol 2008; 6: e107.
8. Greenawalt DM, Dobrin R, Chudin E et al. A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. Genome Res 2011; 21: 1008 1016.
9. Hao K, Bosse Y, Nickle DC et al. Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet 2012; 8: e1003029.
10. Emilsson V, Thorleifsson G, Zhang B et al. Genetics of gene expression and its effect on disease. Nature 2008; 452: 423 428.
11. Lamontagne M, Timens W, Hao K et al. Genetic regulation of gene expression in the lung identifies CST3 and CD22 as potential causal genes for airflow obstruction. Thorax 2014; 69: 997 1004.
12. Battle A, Montgomery SB. Determining causality and consequence of expression quantitative trait loci. Hum Genet 2014; 133: 727 735.
13. Howie B, Fuchsberger C, Stephens M et al. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 2012; 44: 955 959.
14. Hou L, Zhao H. A review of post-GWAS prioritization approaches. Front Genet 2013; 4: 280.
15. Sandborn WJ, Gasink C, Gao L-L et al. Ustekinumab induction and maintenance therapy in refractory Crohns disease. N Engl J Med 2012; 367: 1519 1528.
16. Xie D, Boyle AP, Wu L et al. Dynamic trans-Acting factor colocalization in human cells. Cell 2013; 155: 713 724.
17. Kabakchiev B, Silverberg MS. Expression quantitative trait loci analysis identifies associations between genotype and gene expression in human intestine. Gastroenterology 2013; 144: 1488 1496, 1496.e1-3.
18. Hindorff LA, Sethupathy P, Junkins HA et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009; 106: 9362 9367.
19. Laurie CC, Doheny KF, Mirel DB et al. Quality control and quality assurance in genotypic data for genome-wide association studies. Genet Epidemiol 2010; 34: 591 602.
20. Welter D, MacArthur J, Morales J et al. The NHGRI GWAS Catalog, a curated resource of SNP-Trait associations. Nucleic Acids Res 2014; 42: D1001 D1006.
21. Moffatt MF, Gut IG, Demenais F et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010; 363: 1211 1221.
22. Luo W, Obeidat M, Di Narzo AF et al. Airway epithelial expression quantitative trait loci reveal genes underlying asthma and other airway diseases. Am J Respir Cell Mol Biol 2016; 54: 177 187.
23. Christodoulou K, Wiskin AE, Gibson J et al. Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes. Gut 2013; 62: 977 984.
24. McCall MN, Jaffee HA, Zelisko SJ et al. The Gene Expression Barcode 3.0: improved data processing and mining tools. Nucleic Acids Res 2014; 42: D938 D943.
25. Mayne CG, Williams CB. Induced and natural regulatory T cells in the development of inflammatory bowel disease. Inflamm Bowel Dis 2013; 19: 1772 1788.
26. Uhlig HH. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut 2013; 62: 1795 1805.
27. Le Bourhis L, Mburu YK, Lantz O. MAIT cells, surveyors of a new class of antigen: development and functions. Curr Opin Immunol 2013; 25: 174 180.
28. Serriari NE, Eoche M, Lamotte L et al. Innate mucosal-Associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clini Expe Immunol 2014; 176: 266 274.
29. Petretto E, Bottolo L, Langley SR et al. New insights into the genetic control of gene expression using a Bayesian multi-Tissue approach. PLoS Comput Biol 2010; 6: e1000737.
30. Di Narzo A, Cheng H, Lu J et al. Meta-eQTL: A tool set for flexible eQTL meta-Analysis. BMC Bioinformatics 2014; 15: 392.
31. Sul JH, Han B, Ye C et al. Effectively identifying eQTLs from multiple tissues by combining mixed model and meta-Analytic approaches. PLoS Genet 2013; 9: e1003491.
32. Flutre T, Wen X, Pritchard J et al. A statistical framework for joint eQTL analysis in multiple tissues. PLoS Genet 2013; 9: e1003486.
33. Singh T, Levine AP, Smith PJ et al. Characterization of expression quantitative trait loci in the human colon. Inflamm Bowel Dis 2015; 21: 251 256.
34. Hulur I, Gamazon ER, Skol AD et al. Enrichment of inflammatory bowel disease and colorectal cancer risk variants in colon expression quantitative trait loci. BMC Genom 2015; 16: 138.
35. Garg P, Vijay-Kumar M, Wang L et al. Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis. AM J Physiol Gastrointest Liver Physiol 2009; 296: G175 G184.
36. Dornier E, Coumailleau F, Ottavi JF et al. TspanC8 tetraspanins regulate ADAM10/ Kuzbanian trafficking and promote Notch activation in flies and mammals. J Cell Biol 2012; 199: 481 496.
37. Tsai YH, VanDussen KL, Sawey ET et al. ADAM10 regulates Notch function in intestinal stem cells of mice. Gastroenterology 2014; 147: 822 834.e13.
38. Hong SH, Goh SH, Lee SJ et al. Upregulation of adenylate cyclase 3 (ADCY3) increases the tumorigenic potential of cells by activating the CREB pathway. Oncotarget 2013; 4: 1791 1803.
39. Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet Part C: Semin Med Genet 2006; 142C: 77 85.
40. Odievre MH, Chretien D, Munnich A et al. A novel mutation in the dihydrolipoamide dehydrogenase E3 subunit gene (DLD) resulting in an atypical form of alpha-ketoglutarate dehydrogenase deficiency. Hum Mutat 2005; 25: 323 324.
41. Quintana E, Pineda M, Font A et al. Dihydrolipoamide dehydrogenase (DLD) deficiency in a Spanish patient with myopathic presentation due to a new mutation in the interface domain. J Inherit Metab Dis 2010; 33 (Suppl 3): S315 S319.
42. Uchida H, Yamamoto H, Kisaki Y et al. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg 2004; 39: 634 636.
43. Stamatakos M, Douzinas E, Stefanaki C et al. Ischemic colitis: surging waves of update. Tohoku J Exp Med 2009; 218: 83 92.
44. Heidemann J, Kebschull M, Tepasse PR et al. Regulated expression of leukocyte-specific transcript (LST) 1 in human intestinal inflammation. Inflamm Res 2014; 63: 513 517.
45. Schiller C, Diakopoulos KN, Rohwedder I et al. LST1 promotes the assembly of a molecular machinery responsible for tunneling nanotube formation. J Cell Sci 2013; 126: 767 777.
46. Krausgruber T, Blazek K, Smallie T et al. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 2011; 12: 231 238.
47. Cano-Martinez D. P052 Allograft inflammatory factor-1 (AIF-1) stimulates Th1 differentiation of human T-cells and protects them from apoptosis. J Chrons Colitis 2015;9 (Suppl 1): S103.
48. Bergeret E, Perrin J, Williams M et al. TM9SF4 is required for Drosophila cellular immunity via cell adhesion and phagocytosis. J Cell Sci 2008; 121: 3325 3334.
49. Kang MJ, Yu HS, Seo JH et al. GSDMB/ORMDL3 variants contribute to asthma susceptibility and eosinophil-mediated bronchial hyperresponsiveness. Hum Immunol 2012; 73: 954 959.
50. Ha SG, Ge XN, Bahaie NS et al. ORMDL3 promotes eosinophil trafficking and activation via regulation of integrins and CDNat Commun 2013; 4: 2479.
51. Kerr SC, Carrington SD, Oscarson S et al. Intelectin-1 is a prominent protein constituent of pathologic mucus associated with eosinophilic airway inflammation in asthma. Am J Respir Criti Care Med 2014; 189: 1005 1007.
52. Tang R, Yang G, Zhang S et al. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-Alpha in inflammatory bowel disease. Inflamm Bowel Dis 2014; 20: 1950 1961.
53. Gonsky R, Deem RL, Targan SR. Multiple activating and repressive cis-promoter regions regulate TNFSF15 expression in human primary mononuclear cells. Cytokine 2013; 63: 36 42.
54. Mahrour N, Redwine WB, Florens L et al. Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to Elongin BC-based ubiquitin ligases. J Biol Chem 2008; 283: 8005 8013.
55. Mao X, Gluck N, Li D et al. GCN5 is a required cofactor for a ubiquitin ligase that targets NFkappaB/ RelA. Genes Dev 2009; 23: 849 861.
56. Pacaud R, Sery Q, Oliver L et al. DNMT3L interacts with transcription factors to target DNMT3L/DNMT3B to specific DNA sequences: role of the DNMT3L/DNMT3B/p65-NFkappaB complex in the (de-)methylation of TRAFBiochimie 2014; 104: 36 49.
57. Qiao YQ, Shen J, Gu Y et al. Gene expression of tumor necrosis factor receptor associatedfactor (TRAF)-1 and TRAF-2 in inflammatory bowel disease. J Digest Dis 2013; 14: 244 250.
58. Fransen K, Visschedijk MC, van Sommeren S et al. Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohns disease. Hum Mol Genet 2010; 19: 3482 3488.
59. Fu B, Li S, Wang L et al. The ubiquitin conjugating enzyme UBE2L3 regulates TNFalphainduced linear ubiquitination. Cell Res 2014; 24: 376 379.
60. Palmieri G, Bergamo P, Luini A et al. Acylpeptide hydrolase inhibition as targeted strategy to induce proteasomal down-regulation. PloS One 2011; 6: e25888.
61. Kim E, Tyagi R, Lee JY et al. Inositol polyphosphate multikinase is a coactivator for serum response factor-dependent induction of immediate early genes. Proc Natl Acad Sci USA 2013; 110: 19938 19943.
62. Jang CW, Chen CH, Chen CC et al. TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nature Cell Biol 2002; 4: 51 58.
63. Lei Y, Wen H, Ting JP. The NLR protein, NLRX1, and its partner, TUFM, reduce type I interferon, and enhance autophagy. Autophagy 2013; 9: 432 433.
64. Patergnani S, Marchi S, Rimessi A et al. PRKCB/protein kinase C, beta and the mitochondrial axis as key regulators of autophagy. Autophagy 2013; 9: 1367 1385.
65. Wang LJ, Huang HY, Huang MP et al. The microtubule-Associated protein EB1 links AIM2 inflammasomes with autophagy-dependent secretion. J Biol Chem 2014; 289: 29322 29333.
66. Parkhouse R, Boyle JP, Mayle S et al. Interaction between NOD2 and CARD9 involves the NOD2 NACHTand the linker region between the NOD2 CARDs and NACHT domain. FEBS Lett 2014; 588: 2830 2836.
67. Sokol H, Conway KL, Zhang M et al. Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice. Gastroenterology 2013; 145: 591 601.e3.
68. Lees CW, Barrett JC, Parkes M et al. New IBD genetics: common pathways with other diseases. Gut 2011; 60: 1739 1753.
69. Cooke J, Zhang H, Greger L et al. Mucosal genome-wide methylation changes in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 2128 2137.
70. Schram AW, Baas R, Jansen PW et al. A dual role for SAGA-Associated factor 29 (SGF29) in ER stress survival by coordination of both histone H3 acetylation and histone H3 lysine-4 trimethylation. PloS One 2013; 8: e70035.
71. McNerney ME, Lee KM, Kumar V. 2B4 (CD244) is a non-MHC binding receptor with multiple functions on natural killer cells and CD8+ T cells. Mol Immunol 2005; 42: 489 494.
72. Roncagalli R, Hauri S, Fiore F et al. Quantitative proteomics analysis of signalosome dynamics in primary T cells identifies the surface receptor CD6 as a Lat adaptor-independent TCR signaling hub. Nat Immunol 2014; 15: 384 392.
73. Garcia Santana CA, Tung JW, Gulnik S. Human treg cells are characterized by low/negative CD6 expression. Cytometry A 2014; 85: 901 908.
74. Altin JA, Daley SR, Howitt J et al. Ndfip1 mediates peripheral tolerance to self and exogenous antigen by inducing cell cycle exit in responding CD4+ T cells. Proc Natl Acad Sci USA 2014; 111: 2067 2074.
75. Beal AM, Ramos-Hernandez N, Riling CR et al. TGF-beta induces the expression of the adaptor Ndfip1 to silence IL-4 production during iTreg cell differentiation. Nat Immunol 2012; 13: 77 85.
76. Xue L, Qiu H, Ma J et al. ZNF300, a recently identified human transcription factor, activates the human IL-2Rbeta promoter through the overlapping ZNF300/EGR1 binding site. Cell Mol Biol Lett 2010; 15: 530 540.
77. Rani A, Greenlaw R, Runglall M et al. FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cells. PloS One 2014; 9: e90370.
78. Ciofani M, Madar A, Galan C et al. A validated regulatory network for Th17 cell specification. Cell 2012; 151: 289 303.
79. Kennedy JM, Fodil N, Torre S et al. CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammation. J Exp Med 2014; 211: 2519 2535.
80. Nasir A, Norton JD, Baou M et al. ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA. PloS One 2012; 7: e52187